Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, GeneArt Add Insect, Mammalian Synthetic Genes to Marketing Collaboration

NEW YORK (GenomeWeb News) – GeneArt said today it has extended its strategic collaboration with Qiagen to include the sale of synthetic genes optimized for mammalian and insect cells online through Qiagen’s GeneGlobe web portal.
 
GeneArt said it will optimize and synthesize the QIAgenes, which will be aimed at customers in the pharmaceutical and biotechnology industries and academia.
 
The companies agreed in May of this year to collaborate on marketing a set of plasmids containing synthetic genes that represent the entire human genome.
 
“Since the launch of our expression kits for use in E. coli cells in May, we have received a high number of requests for these two additional options,” Qiagen Global Product Manager Ute Boronowsky said in a statement.
 
GeneArt also said that marketing the QIAgenes products as a standardized catalog product complements the company’s existing business to tailor gene sequences for individual customer requests.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more